Solid Self-Microemulsifying Drug Delivery Systems (S-SMEDDS): Advances in Oral Bioavailability Enhancement

Authors

  • Vatsal Kansara
  • Sanjesh Rathi
  • Shubham Singh

Keywords:

Solid Self-Microemulsifying Drug Delivery Systems (S-SMEDDS); Oral bioavailability; Lipid-based drug delivery; Quality by Design (QbD)

Abstract

The oral delivery of poorly soluble drugs remains a major challenge in pharmaceutical development due to limited dissolution and low systemic availability, particularly for compounds belonging to Biopharmaceutics Classification System (BCS) Class II and IV. Lipid-based drug delivery systems, especially Self-Microemulsifying Drug Delivery Systems (SMEDDS), have shown considerable potential in enhancing solubilization and absorption through spontaneous formation of fine emulsions in the gastrointestinal environment. However, conventional liquid SMEDDS suffer from limitations such as instability, leakage, and precipitation upon dilution, restricting their practical application. Solid Self-Microemulsifying Drug Delivery Systems (S-SMEDDS) have emerged as an advanced alternative, integrating the advantages of lipid-based formulations with the stability and convenience of solid dosage forms. Upon dispersion, S-SMEDDS rapidly reconstitute into nano-sized microemulsions, improving drug dissolution, permeability, and bioavailability. This review comprehensively discusses formulation strategies, excipient selection, and solidification techniques involved in the development of S-SMEDDS. The mechanisms of bioavailability enhancement, including improved solubilization, increased surface area, lymphatic transport, and inhibition of efflux transporters, are critically analyzed. Recent advances such as polymer-based and supersaturable systems, along with lipid–polymer hybrid approaches, are highlighted for their role in maintaining supersaturation and preventing drug precipitation. The application of Quality by Design (QbD) principles for systematic optimization and robust product development is also emphasized. Overall, S-SMEDDS represent a promising and versatile platform for enhancing oral bioavailability, with significant potential for future pharmaceutical innovation and commercialization..

Downloads

Download data is not yet available.

References

M. S. Alqahtani, M. Kazi, M. A. Alsenaidy, and M. Z. Ahmad, “Advances in Oral Drug Delivery,” Frontiers in Pharmacology, vol. 12. Frontiers Media, Feb. 19, 2021. doi: 10.3389/fphar.2021.618411.

[2] L. Kumari et al., “Advancement in Solubilization Approaches: A Step towards Bioavailability Enhancement of Poorly Soluble Drugs,” Life, vol. 13, no. 5, p. 1099, Apr. 2023, doi: 10.3390/life13051099.

[3] R. Kumar, M. RAJESH, and L. SUBRAMANIAN, “Solubility enhancement techniques: A comprehensive review,” World Journal of Biology Pharmacy and Health Sciences, vol. 13, no. 3. p. 414, Mar. 18, 2023. doi: 10.30574/wjbphs.2023.13.3.0125.

[4] J. Khan et al., Pakistan Journal of Pharmaceutical Sciences, vol. 36, no. 1, Jan. 2023, doi: 10.36721/pjps.2023.36.1.sp.265-272.1.

[5] K. R. Gupta, M. R. Dakhole, K. S. Jinnawar, and M. Umekar, “Strategies for improving hydrophobic drugs solubility and bioavailability,” International Journal of Pharmaceutical Chemistry and Analysis, vol. 10, no. 3, p. 164, Sep. 2023, doi: 10.18231/j.ijpca.2023.029.

[6] S. B. Pund, “A Review on Lipid Based Oral Drug Delivery Systems,” International Journal of Pharmaceutical Sciences Review and Research, vol. 69, no. 1, Jul. 2021, doi: 10.47583/ijpsrr.2021.v69i01.013.

[7] S. Vaghela, S. Chaudhary, and A. Chaudhary, “A Systemic Review on the Self Micro Emulsifying Drug Delivery System,” International Journal of Pharmaceutical Sciences Review and Research, vol. 69, no. 1, Jul. 2021, doi: 10.47583/ijpsrr.2021.v69i01.027.

[8] G. Muniandy and S. X. Chong, “Optimisation of Curcumin Microemulsions Using Palm Oil,” Malaysian Journal of Pharmaceutical Sciences, vol. 20, no. 2, p. 27, Nov. 2022, doi: 10.21315/mjps2022.20.2.3.

[9] M. R. Reddy and K. S. Gubbiyappa, “A COMPREHENSIVE REVIEW ON SUPERSATURABLE SELF-NANOEMULSIFYING DRUG DELIVERY SYSTEM,” Asian Journal of Pharmaceutical and Clinical Research. Innovare Academic Sciences, p. 40, Aug. 07, 2021. doi: 10.22159/ajpcr.2021.v14i8.41987.

[10] R. Annisa, R. Mutiah, M. Yuwono, and E. Hendradi, “NANOTECHNOLOGY APPROACH-SELF NANOEMULSIFYING DRUG DELIVERY SYSTEM (SNEDDS),” International Journal of Applied Pharmaceutics, p. 12, Jul. 2023, doi: 10.22159/ijap.2023v15i4.47644.

[11] S. D. Silberstein, E. L. H. Spierings, and T. Kunkel, “Celecoxib Oral Solution and the Benefits of Self-Microemulsifying Drug Delivery Systems (SMEDDS) Technology: A Narrative Review,” Pain and Therapy, vol. 12, no. 5. Adis, Springer Healthcare, p. 1109, Jun. 17, 2023. doi: 10.1007/s40122-023-00529-7.

[12] M. P. Divate, S. U. Bawkar, R. D. Chakole, and M. S. Charde, “SELF NANO-EMULSIFYING DRUG DELIVERY SYSTEM: A REVIEW,” Journal of Advanced Scientific Research, vol. 12. p. 1, Oct. 31, 2021. doi: 10.55218/jasr.s2202112301.

[13] S. Tanga, P. Ramburrun, and M. Aucamp, “From Liquid SNEDDS to Solid SNEDDS: A Comprehensive Review of Their Development and Pharmaceutical Applications,” The AAPS Journal, vol. 28, no. 1. Springer Science+Business Media, Oct. 30, 2025. doi: 10.1208/s12248-025-01167-x.

[14] N. Kusumorini, A. K. Nugroho, S. Pramono, and R. Martien, “Spray-dried self-nanoemulsifying drug delivery systems as carriers for the oral delivery of piperine: Characterization and in vitro evaluation,” Journal of Applied Pharmaceutical Science, Jan. 2022, doi: 10.7324/japs.2022.120906.

[15] Rawat and R. Srivastava, “A review of strategies for the development of solid self-microemulsifying drug delivery system,” Journal of Pharmacognosy and Phytochemistry, vol. 13, no. 3. AkiNik Publications, p. 200, May 01, 2024. doi: 10.22271/phyto.2024.v13.i3c.14960.

[16] H. M. Mansour, A. E.-G. H. A. El-Gawad, and M. F. Boughdady, “Development of Linagliptin Ultra Fine Solid Supersaturated Bio-SNEDDS Using Triangular Mixture Design for Enhancement of Oral Bioavailability: Impact of P-gp Inhibition,” Journal of Pharmaceutical Research International, vol. 35, no. 30, p. 23, Nov. 2023, doi: 10.9734/jpri/2023/v35i307459.

[17] S. Almawash, “Oral Bioavailability Enhancement of Anti-Cancer Drugs Through Lipid Polymer Hybrid Nanoparticles,” Pharmaceutics, vol. 17, no. 3, p. 381, Mar. 2025, doi: 10.3390/pharmaceutics17030381.

[18] Y. S. Baghel and S. Bhattacharya, “Lipid Polymeric Hybrid Nanoparticles: Formulation Techniques and Effects on Glioblastoma,” Pharmaceutical Sciences, Sep. 2021, doi: P. Gangane, K. Singh, and V. Rabade, “Enhancement of the Solubility of Lipophilic Drug by Self-Micro Emulsifying Drug Delivery System (SMEDDS) For Oral Administration,” Indian Journal of Pharmaceutical Education and Research, vol. 57, Aug. 2023, doi: 10.5530/ijper.57.3s.59.

[19] L. Badhei, D. Mishra, P. Nandi, and H. B. Samal, “Self-Micro-Emulsifying Drug Delivery Systems: In-Depth Review onEnhancing Solubility and Therapeutic Efficacy of BCS Class II Drugs,” Current Drug Safety, vol. 20, Mar. 2025, doi: 10.2174/0115748863354153250225074632.

[20] D. Saikumar and L. P. J, “A Literature Review on Self Nanoemulsifying Drug Delivery System (SNEDDS),” International Journal of Pharmaceutical Sciences Review and Research, vol. 70, no. 1. Sep. 15, 2021. doi: 10.47583/ijpsrr.2021.v70i01.011.

[21] M. R. Reddy and K. S. Gubbiyappa, “Formulation development, optimization and characterization of Pemigatinib-loaded supersaturable self-nanoemulsifying drug delivery systems,” Future Journal of Pharmaceutical Sciences, vol. 8, no. 1, Nov. 2022, doi: 10.1186/s43094-022-00434-4.

[22] V. Bhatia and M. A. Paul, “Development of a Solid Self-emulsifying Drug Delivery System of Boswellia serrata,” Pharmacognosy Research, vol. 14, no. 4, p. 429, Oct. 2022, doi: 10.5530/pres.14.4.63.

[23] N. BAYTOK and O. M. Saka, “SELF EMULSIFYING DRUG DELIVERY SYSTEMS- An Ovierview,” Ankara Universitesi Eczacilik Fakultesi Dergisi, Feb. 2023, doi: 10.33483/jfpau.1244378.

[24] D. P. Ramachandra and P. Sudheer, “Self-micro Emulsifying Drug Delivery via Intestinal Lymphatics: A LucrativeApproach to Drug Targeting,” Pharmaceutical Nanotechnology, vol. 11, no. 3, p. 238, Feb. 2023, doi: 10.2174/2211738511666230112123235.

[25] M. Kovacevic, M. Gašperlin, and A. Z. Pobirk, “Lipid-based systems with precipitation inhibitors as formulation approach to improve the drug bioavailability and/or lower its dose: a review,” Acta Pharmaceutica, vol. 74, no. 2. De Gruyter Open, p. 201, May 30, 2024. doi: 10.2478/acph-2024-0023.

[26] P. Mohite, S. Singh, A. Pawar, A. Sangale, and B. G. Prajapati, “Lipid-based oral formulation in capsules to improve the delivery of poorly water-soluble drugs,” Frontiers in Drug Delivery, vol. 3. Frontiers Media, Aug. 24, 2023. doi: 10.3389/fddev.2023.1232012.

[27] K. W. S. Al-Janabi, S. Nazar, and A. Alhammid, “Preparation and Characterization of Ticagrelor Solid Self nano-emulsion,” Journal of Pharmaceutical Negative Results, vol. 13, no. 3, Jan. 2022, doi: 10.47750/pnr.2022.13.03.045.

[28] M. Parvathaneni, H. Battu, and B. Sudhakar, “A Review on Hot Melt Extrusion Coupled Novel Drug Delivery Systems,” Journal of Drug Delivery and Therapeutics, vol. 12, no. 5. Society of Pharmaceutical Tecnocrats, p. 201, Sep. 15, 2022. doi: 10.22270/jddt.v12i5.5646.

[29] M. Kumar, P. A. Chawla, A. Faruk, V. Chawla, S. Thakur, and S. K. Jain, “Development of superior chitosan–EDTA microparticles as an adsorbent base for solidifying the self-emulsifying drug delivery systems,” Future Journal of Pharmaceutical Sciences, vol. 10, no. 1, Feb. 2024, doi: 10.1186/s43094-024-00588-3.

[30] Z. Chen et al., “A comparative study on the preparation and evaluation of solubilizing systems for silymarin,” Drug Delivery and Translational Research, vol. 14, no. 6, p. 1616, Nov. 2023, doi: 10.1007/s13346-023-01476-8.

[31] R. Verma, D. Kaushik, P. Pandey, and P. Jalwal, “Solid-SMEDDS: Techniques of Solidification and Recent Advancements,” in BENTHAM SCIENCE PUBLISHERS eBooks, 2021, p. 134. doi: 10.2174/9789814998000121010010.

[32] P. Uttreja et al., “Self-Emulsifying Drug Delivery Systems (SEDDS): Transition from Liquid to Solid—A Comprehensive Review of Formulation, Characterization, Applications, and Future Trends,” Pharmaceutics, vol. 17, no. 1, p. 63, Jan. 2025, doi: 10.3390/pharmaceutics17010063.

[33] R. S. Sura, C. SUBRAHMANYAM, and S. S. Rachamalla, “Development and Evaluation of Self Micro Emulsifying Drug Delivery System (SMEDDS) for Nebivolol Hydrochloride,” International Journal of Life Science and Pharma Research, Jul. 2022, doi: 10.22376/ijpbs/lpr.2021.11.6.p83-97.

[34] J. Mandić et al., “Evaluation of solid carvedilol-loaded SMEDDS produced by the spray drying method and a study of related substances,” International Journal of Pharmaceutics, vol. 605, p. 120783, Jun. 2021, doi: 10.1016/j.ijpharm.2021.120783.

[35] D. Nyavanandi et al., “Twin Screw Melt Granulation: A Single Step Approach for Developing Self-Emulsifying Drug Delivery System for Lipophilic Drugs,” Pharmaceutics, vol. 15, no. 9, p. 2267, Sep. 2023, doi: 10.3390/pharmaceutics15092267.

[36] K. Baek and S. G. Jin, “Solidification Materials and Technology for Solid Self-Emulsifying Drug Delivery Systems,” Pharmaceuticals, vol. 18, no. 10, p. 1550, Oct. 2025, doi: 10.3390/ph18101550.

[37] K. C. Panigrahi, C. N. Patra, M. E. B. Rao, G. K. Jena, and L. Sahoo, “SEDDS Basic Design and Recent Formulation Advancement: A ConcurrentReview,” Pharmaceutical Nanotechnology, vol. 10, no. 4, p. 289, Aug. 2022, doi: 10.2174/2211738510666220817124744.

[38] P. Mohapatra and N. Chandrasekaran, “OPTIMIZATION AND CHARACTERIZATION OF ESSENTIAL OILS FORMULATION FOR ENHANCED STABILITY AND DRUG DELIVERY SYSTEM OF MEFLOQUINE,” International Journal of Applied Pharmaceutics, p. 145, Sep. 2023, doi: 10.22159/ijap.2023v15i5.48624.

[39] V. Changediya, “Nanoemulsions: A Recent Drug Delivery Tool,” in IntechOpen eBooks, IntechOpen, 2024. doi: 10.5772/intechopen.1005266.

[40] Bamanna, A. Rajora, and K. Nagpal, “Enhancing Microemulsion-Based Therapeutic Drug Delivery: Exploring Surfactants, Co-Surfactants, and Quality-by-Design Strategies within Pseudoternary Phase Diagrams,” Critical Reviews in Therapeutic Drug Carrier Systems, vol. 42, no. 2, p. 35, Aug. 2024, doi: 10.1615/critrevtherdrugcarriersyst.2024053427.

[41] J. Appelhaus, K. E. Steffens, and K. Wagner, “Effect of Liquid Load Level and Binder Type on the Tabletability of Mesoporous Silica Based Liquisolids,” AAPS PharmSciTech, vol. 25, no. 8, Oct. 2024, doi: 10.1208/s12249-024-02958-9.

[42] N. Hasan, D. Almalki, M. J. k. Althuwaybi, and H. M. Alshehri, “SMEDDS TABLET: COMPATABILITY OF SOLID SMEDDS USING VARIOUS PHARMACEUTICAL TABLET EXCIPIENTS,” International Journal of Pharmacy and Pharmaceutical Sciences, vol. 8, no. 9, p. 246, Sep. 2016, doi: 10.22159/ijpps.2016v8i9.13409.

[43] N. Gahlawat, R. Verma, and D. Kaushik, Asian Journal of Pharmaceutics, vol. 13, no. 2, Jun. 2019, doi: 10.22377/ajp.v13i02.3101.

[44] H. Cao et al., “Available technologies on improving the stability of polyphenols in food processing,” Food Frontiers, vol. 2, no. 2, p. 109, Mar. 2021, doi: 10.1002/fft2.65.

[45] B. S. Neves, R. C. Gonçalves, J. F. Mano, and M. B. Oliveira, “Controlling the diffusion of small molecules from matrices processed by all-aqueous methodologies: towards the development of green pharmaceutical products,” Green Chemistry, vol. 26, no. 8, p. 4417, Jan. 2024, doi: 10.1039/d3gc04183b.

[46] Serrano, M. C. Viana, N. V. Pinto, E. B. Lages, G. Carneiro, and G. S. M. Borges, “The Use of Design of Experiments (DoE) Approaches for the Development of Self-Emulsifying Drug Delivery Systems (SEDDS),” Applied Nano, vol. 6, no. 1, p. 4, Feb. 2025, doi: 10.3390/applnano6010004.

[47] S. T. Buckley, K. J. Frank, G. Fricker, and M. Brandl, “Biopharmaceutical classification of poorly soluble drugs with respect to ‘enabling formulations,’” European Journal of Pharmaceutical Sciences, vol. 50, no. 1. Elsevier BV, p. 8, Apr. 16, 2013. doi: 10.1016/j.ejps.2013.04.002.

[48] B. Chatterjee, S. H. Almurisi, A. A. M. Dukhan, U. K. Mandal, and P. Sengupta, “Controversies with self-emulsifying drug delivery system from pharmacokinetic point of view,” Drug Delivery, vol. 23, no. 9, p. 3639, Aug. 2016, doi: 10.1080/10717544.2016.1214990.

[49] Sanjesh G. Rathi, Kaushik Kamani, Bhoomi Patel, Shubham Singh, Yash Patel. Formulation and Evaluation of Voriconazole Emulgel. Research Journal Pharmacy and Technology. 2025;18(8):3917-2. doi: 10.52711/0974-360X.2025.00563

[50] O. Rezhdo, L. Speciner, and R. L. Carrier, “Lipid-associated oral delivery: Mechanisms and analysis of oral absorption enhancement,” Journal of Controlled Release, vol. 240. Elsevier BV, p. 544, Aug. 10, 2016. doi: 10.1016/j.jconrel.2016.07.050.

[51] L. Charles and A. A. Attama, “Current State of Nanoemulsions in Drug Delivery,” Journal of Biomaterials and Nanobiotechnology, vol. 2, no. 5, p. 626, Jan. 2011, doi: 10.4236/jbnb.2011.225075.

[52] K. Čerpnjak, A. Z. Pobirk, M. Gašperlin, and F. Vrečer, “Lipid-based systems as a promising approach for enhancing the bioavailability of poorly water-soluble drugs,” Acta Pharmaceutica, vol. 63, no. 4. De Gruyter Open, p. 427, Dec. 01, 2013. doi: 10.2478/acph-2013-0040.

[53] S. Maher, R. J. Mrsny, and D. J. Brayden, “Intestinal permeation enhancers for oral peptide delivery,” Advanced Drug Delivery Reviews, vol. 106. Elsevier BV, p. 277, Jun. 20, 2016. doi: 10.1016/j.addr.2016.06.005.

[54] J. L. Zaro, “Lipid-Based Drug Carriers for Prodrugs to Enhance Drug Delivery,” The AAPS Journal, vol. 17, no. 1. Springer Science+Business Media, p. 83, Sep. 30, 2014. doi: 10.1208/s12248-014-9670-z.

[55] V. Franco, P. Gershkovich, E. Perucca, and M. Bialer, “The Interplay Between Liver First-Pass Effect and Lymphatic Absorption of Cannabidiol and Its Implications for Cannabidiol Oral Formulations,” Clinical Pharmacokinetics, vol. 59, no. 12, p. 1493, Aug. 2020, doi: 10.1007/s40262-020-00931-w.

[56] Cherniakov, A. J. Domb, and A. Hoffman, “Self-nano-emulsifying drug delivery systems: an update of the biopharmaceutical aspects,” Expert Opinion on Drug Delivery, vol. 12, no. 7, p. 1121, Jan. 2015, doi: 10.1517/17425247.2015.999038.

[57] M. Abdulkarim, P. Sharma, and M. Gumbleton, “Self-emulsifying drug delivery system: Mucus permeation and innovative quantification technologies,” Advanced Drug Delivery Reviews, vol. 142. Elsevier BV, p. 62, Mar. 01, 2019. doi: 10.1016/j.addr.2019.04.001.

[58] S. Chaturvedi, A. Verma, and V. A. Saharan, “Lipid Drug Carriers for Cancer Therapeutics: An Insight into Lymphatic Targeting, P-gp, CYP3A4 Modulation and Bioavailability Enhancement,” Advanced Pharmaceutical Bulletin, vol. 10, no. 4. Tabriz University of Medical Sciences, p. 524, Aug. 09, 2020. doi: 10.34172/apb.2020.064.

[59] S. Alshehri et al., “Flufenamic Acid-Loaded Self-Nanoemulsifying Drug Delivery System for Oral Delivery: From Formulation Statistical Optimization to Preclinical Anti-Inflammatory Assessment,” Journal of Oleo Science, vol. 69, no. 10, p. 1257, Jan. 2020, doi: 10.5650/jos.ess20070.

[60] T. J. Dening, S. Rao, N. Thomas, and C. A. Prestidge, “Novel Nanostructured Solid Materials for Modulating Oral Drug Delivery from Solid-State Lipid-Based Drug Delivery Systems,” The AAPS Journal, vol. 18, no. 1. Springer Science+Business Media, p. 23, Sep. 09, 2015. doi: 10.1208/s12248-015-9824-7.

[61] Becker, S. Salar-Behzadi, and A. Zimmer, “Solvent-Free Melting Techniques for the Preparation of Lipid-Based Solid Oral Formulations,” Pharmaceutical Research, vol. 32, no. 5. Springer Science+Business Media, p. 1519, Mar. 18, 2015. doi: 10.1007/s11095-015-1661-y.

[62] Dharmendra Singh Rajput, Mitul Bhoi, Shubham Singh, Comment on “Fennel essential oil and its nanoemulsion modulate macrophage-mediated inflammatory responses and promote pressure ulcer healing.” International Immunopharmacology. 2026; 173:116184. https://doi.org/10.1016/j.intimp.2026.116184

[63] Y. Chen, C. Chen, J. Zheng, Z. Chen, Q. Shi, and L. Hong, “Development of a Solid Supersaturatable Self-Emulsifying Drug Delivery System of Docetaxel with Improved Dissolution and Bioavailability,” Biological and Pharmaceutical Bulletin, vol. 34, no. 2, p. 278, Jan. 2011, doi: 10.1248/bpb.34.278.

[64] S. Chime, “Lipid-based drug delivery systems (LDDS): Recent advances and applications of lipids in drug delivery,” African Journal of Pharmacy and Pharmacology, vol. 7, no. 48, p. 3034, Dec. 2013, doi: 10.5897/ajppx2013.0004.

[65] N. Li and L. S. Taylor, “Tailoring supersaturation from amorphous solid dispersions,” Journal of Controlled Release, vol. 279, p. 114, Apr. 2018, doi: 10.1016/j.jconrel.2018.04.014.

[66] K. Arun, R. Vodeti, B. Shrivastava, and V. Bakshi, “Integrated Quality by Design Approach for Developing Nanolipidic Drug Delivery Systems of Olmesartan Medoxomil with Enhanced Antihypertensive Action,” Advanced Pharmaceutical Bulletin, vol. 10, no. 3, p. 379, May 2020, doi: 10.34172/apb.2020.046.

[67] X. Li, Q. Yuan, Y. Huang, Y. Zhou, and Y. Liu, “Development of Silymarin Self-Microemulsifying Drug Delivery System with Enhanced Oral Bioavailability,” AAPS PharmSciTech, vol. 11, no. 2, p. 672, Apr. 2010, doi: 10.1208/s12249-010-9432-x.

[68] P. B. Aru, M. S. Gulhane, V. A. Katekar, and S. P. Deshmukh, “Quality by Design (QbD) in pharmaceutical development: A comprehensive review,” GSC Biological and Pharmaceutical Sciences, vol. 26, no. 1. p. 328, Jan. 29, 2024. doi:

[69] Salawi, “Self-emulsifying drug delivery systems: a novel approach to deliver drugs,” Drug Delivery, vol. 29, no. 1, p. 1811, Jun. 2022, doi: 10.1080/10717544.2022.2083724.

[70] J. Matić, A. Paudel, H. Bauer, R. A. L. García, K. Biedrzycka, and J. Khinast, “Developing HME-Based Drug Products Using Emerging Science: a Fast-Track Roadmap from Concept to Clinical Batch,” AAPS PharmSciTech, vol. 21, no. 5. Springer Science+Business Media, Jun. 22, 2020. doi: 10.1208/s12249-020-01713-0.

[71] T. Bastogne, “Quality-by-design of nanopharmaceuticals – a state of the art,” Nanomedicine Nanotechnology Biology and Medicine, vol. 13, no. 7. Elsevier BV, p. 2151, Jun. 02, 2017. doi: 10.1016/j.nano.2017.05.014.

[72] D. Panigrahi, P. K. Sahu, S. Swain, and R. K. Verma, “Quality by design prospects of pharmaceuticals application of double emulsion method for PLGA loaded nanoparticles,” SN Applied Sciences, vol. 3, no. 6, May 2021, doi: 10.1007/s42452-021-04609-1.

[73] Rajvi YK, Kumar M, Singh S. Comment on Can cord blood unit selection improve outcomes after single-unit unrelated cord blood transplantation for non-remission acute myeloid leukemia?. Transplant Cell Ther. 2026;S2666-6367(26)00223-X. https://doi.org/10.1016/j.jtct.2026.03.014.

[74] E. B. Haghighi, S. S. Abolmaali, A. Dehshahri, S. A. M. Shaegh, N. Azarpira, and A. M. Tamaddon, “Navigating the intricate in-vivo journey of lipid nanoparticles tailored for the targeted delivery of RNA therapeutics: a quality-by-design approach,” Journal of Nanobiotechnology, vol. 22, no. 1. BioMed Central, Nov. 14, 2024. doi: 10.1186/s12951-024-02972-w.

[75] P. Yadav, V. Rastogi, and A. Verma, “Application of Box–Behnken design and desirability function in the development and optimization of self-nanoemulsifying drug delivery system for enhanced dissolution of ezetimibe,” Future Journal of Pharmaceutical Sciences, vol. 6, no. 1, Mar. 2020, doi: 10.1186/s43094-020-00023-3.

[76] D. G. Sitre and R. K. Kamble, “Articulation of Quality By Design Elements for Product Development and its Unique Applications,” Journal of Drug Delivery and Therapeutics, vol. 10, no. 3, p. 253, May 2020, doi: 10.22270/jddt.v10i3.4080.

[77] M. Patel and R. J. Patel, “Linagliptin loaded Solid-SMEEDS for enhanced solubility and dissolution: Formulation development and optimization by D-optimal design,” Journal of Drug Delivery and Therapeutics, vol. 9, no. 2, p. 47, Mar. 2019, doi: 10.22270/jddt.v9i2.2465.

[78] S. Meirinho, M. Rodrigues, A. O. Santos, A. Falcão, and G. Alves, “Self-Emulsifying Drug Delivery Systems: An Alternative Approach to Improve Brain Bioavailability of Poorly Water-Soluble Drugs through Intranasal Administration,” Pharmaceutics, vol. 14, no. 7, p. 1487, Jul. 2022, doi: 10.3390/pharmaceutics14071487.

[79] López-Vidal et al., “Formulation and optimization of pH-sensitive nanocrystals for improved oral delivery,” Drug Delivery and Translational Research, vol. 14, no. 5, p. 1301, Nov. 2023, doi: 10.1007/s13346-023-01463-z.

[80] P. Baghel, A. Roy, S. Verma, T. Satapathy, and S. Bahadur, “Amelioration of lipophilic compounds in regards to bioavailability as self-emulsifying drug delivery system (SEDDS),” Future Journal of Pharmaceutical Sciences, vol. 6, no. 1, Jun. 2020, doi: 10.1186/s43094-020-00042-0.

[81] S. Ansari et al., “Advancements and Innovations in Herbal and non-herbal, Self-Micro emulsifying Drug Delivery Systems (SMEDDS): A Comprehensive Review,” International Journal of Ayurvedic Medicine, vol. 16, p. 15, Jul. 2025, doi: 10.47552/ijam.v16is2.6202.

[82] G. V. Radha, K. T. Sastri, S. Burada, and J. Rajkumar, “A Systematic Review On Self-Micro Emulsifying Drug Delivery Systems: A Potential Strategy For Drugs With Poor Oral Bioavailability,” International Journal of Applied Pharmaceutics, vol. 11, no. 1. Innovare Academic Sciences, p. 23, Jan. 09, 2019. doi: 10.22159/ijap.2019v11i1.29978.

[83] M. N. A. Shah and A. G. Agrawal, “Self-Microemulsifying System,” in IntechOpen eBooks, IntechOpen, 2019. doi: 10.5772/intechopen.88603

Downloads

Published

2025-12-12

How to Cite

1.
Kansara V, Rathi S, Singh S. Solid Self-Microemulsifying Drug Delivery Systems (S-SMEDDS): Advances in Oral Bioavailability Enhancement. J Neonatal Surg [Internet]. 2025 Dec. 12 [cited 2026 May 9];14(33S):990-1003. Available from: https://jneonatalsurg.com/index.php/jns/article/view/10237

Issue

Vol. 14 No. 33S (2025): Journal of Neonatal Surgery

Section

Original Article

License

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

You are free to:

  • Adapt — remix, transform, and build upon the material for any purpose, even commercially.

Terms:

  • Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
  • No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.